These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 24988946

  • 1. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI.
    Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng R, Wang Y, Huang J, Xu M, Yan J, Yu J.
    FEBS J; 2014 Aug; 281(16):3766-75. PubMed ID: 24988946
    [Abstract] [Full Text] [Related]

  • 2. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1.
    Zhuang M, Gao W, Xu J, Wang P, Shu Y.
    Biochem Biophys Res Commun; 2014 Jun 06; 448(3):315-22. PubMed ID: 24388988
    [Abstract] [Full Text] [Related]

  • 3. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y, Dahiya R.
    Clin Cancer Res; 2011 Aug 15; 17(16):5287-98. PubMed ID: 21159887
    [Abstract] [Full Text] [Related]

  • 4. Oncofetal H19 RNA promotes tumor metastasis.
    Matouk IJ, Raveh E, Abu-lail R, Mezan S, Gilon M, Gershtain E, Birman T, Gallula J, Schneider T, Barkali M, Richler C, Fellig Y, Sorin V, Hubert A, Hochberg A, Czerniak A.
    Biochim Biophys Acta; 2014 Jul 15; 1843(7):1414-26. PubMed ID: 24703882
    [Abstract] [Full Text] [Related]

  • 5. Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.
    Chen WY, Tsai YC, Yeh HL, Suau F, Jiang KC, Shao AN, Huang J, Liu YN.
    Sci Signal; 2017 Aug 15; 10(492):. PubMed ID: 28811384
    [Abstract] [Full Text] [Related]

  • 6. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
    Cai C, Chen QB, Han ZD, Zhang YQ, He HC, Chen JH, Chen YR, Yang SB, Wu YD, Zeng YR, Qin GQ, Liang YX, Dai QS, Jiang FN, Wu SL, Zeng GH, Zhong WD, Wu CL.
    Clin Cancer Res; 2015 Nov 01; 21(21):4922-34. PubMed ID: 26080838
    [Abstract] [Full Text] [Related]

  • 7. The microRNA profile of prostate carcinoma obtained by deep sequencing.
    Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A, Wullich B, Grässer F.
    Mol Cancer Res; 2010 Apr 01; 8(4):529-38. PubMed ID: 20353999
    [Abstract] [Full Text] [Related]

  • 8. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
    Fuse M, Nohata N, Kojima S, Sakamoto S, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, Naya Y, Ichikawa T, Seki N.
    Int J Oncol; 2011 Apr 01; 38(4):1093-101. PubMed ID: 21258769
    [Abstract] [Full Text] [Related]

  • 9. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145.
    Guo W, Ren D, Chen X, Tu X, Huang S, Wang M, Song L, Zou X, Peng X.
    J Cell Biochem; 2013 Jul 01; 114(7):1606-15. PubMed ID: 23355420
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
    Shen PF, Chen XQ, Liao YC, Chen N, Zhou Q, Wei Q, Li X, Wang J, Zeng H.
    Prostate; 2014 May 01; 74(7):756-67. PubMed ID: 24644030
    [Abstract] [Full Text] [Related]

  • 11. Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells.
    Wang L, Alcon A, Yuan H, Ho J, Li QJ, Martins-Green M.
    Integr Biol (Camb); 2011 Jul 01; 3(7):742-54. PubMed ID: 21594291
    [Abstract] [Full Text] [Related]

  • 12. miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1.
    Sun Q, Zhao X, Liu X, Wang Y, Huang J, Jiang B, Chen Q, Yu J.
    Prostate; 2014 Dec 01; 74(16):1613-21. PubMed ID: 25214035
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII.
    Zhang W, Liu J, Qiu J, Fu X, Tang Q, Yang F, Zhao Z, Wang H.
    Oncol Rep; 2016 Dec 01; 36(6):3707-3715. PubMed ID: 27748848
    [Abstract] [Full Text] [Related]

  • 14. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X, Zhou Y, Chen W, Chen L, Lu J, He F, Li X, Zhao L.
    Cell Physiol Biochem; 2018 Dec 01; 51(3):1340-1353. PubMed ID: 30481782
    [Abstract] [Full Text] [Related]

  • 15. microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.
    Mao Y, Chen H, Lin Y, Xu X, Hu Z, Zhu Y, Wu J, Xu X, Zheng X, Xie L.
    Oncol Rep; 2013 Jul 01; 30(1):327-33. PubMed ID: 23670210
    [Abstract] [Full Text] [Related]

  • 16. Long Non-Coding RNA H19 Regulates Human Lens Epithelial Cells Function.
    Liu X, Liu C, Shan K, Zhang S, Lu Y, Yan B, Luo Y.
    Cell Physiol Biochem; 2018 Jul 01; 50(1):246-260. PubMed ID: 30286462
    [Abstract] [Full Text] [Related]

  • 17. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.
    Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung JJ, Kwok TT.
    Carcinogenesis; 2010 Mar 01; 31(3):350-8. PubMed ID: 19926638
    [Abstract] [Full Text] [Related]

  • 18. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
    Kong LM, Liao CG, Zhang Y, Xu J, Li Y, Huang W, Zhang Y, Bian H, Chen ZN.
    Cancer Res; 2014 Jul 15; 74(14):3764-78. PubMed ID: 24906624
    [Abstract] [Full Text] [Related]

  • 19. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
    Vennin C, Spruyt N, Dahmani F, Julien S, Bertucci F, Finetti P, Chassat T, Bourette RP, Le Bourhis X, Adriaenssens E.
    Oncotarget; 2015 Oct 06; 6(30):29209-23. PubMed ID: 26353930
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
    Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, Yeh SD, Hong TM, Chen YL.
    Carcinogenesis; 2013 Mar 06; 34(3):530-8. PubMed ID: 23188675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.